2018
DOI: 10.1007/s11060-018-2881-x
|View full text |Cite
|
Sign up to set email alerts
|

MR-spectroscopic imaging of glial tumors in the spotlight of the 2016 WHO classification

Abstract: MR spectroscopy is a robust tool for predicting the molecular subtype in gliomas and adds important diagnostic information to the preoperative diagnostic work-up of glial tumor patients. MR-spectroscopy could improve radiological diagnostics in the future and potentially influence clinical and surgical decisions to improve individual tumor treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
11
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

3
3

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 34 publications
1
11
0
Order By: Relevance
“…With the IDH1 R132 (Arginine 132) mutation leading to an accumulation of 2 hydroxyglutarate, magnetic resonance spectroscopy (MRS) allows the measurement of this oncometabolite in vivo (49, 50), which has been applied for non-invasively predicting IDH-mutation status in glioma patients (51) and for investigating remote glioma cell infiltration in vivo (52–54). Recent studies even used MRS to identify tumor-specific metabolic profiles and investigated metabolic–transcriptional alterations under consideration of genetic profiles (5557). A multimodal approach combining MRS and a diffusion-based characterization of NAWM microarchitecture may allow future studies to further specify histopathological correlates of NAWM diffusion properties in vivo .…”
Section: Discussionmentioning
confidence: 99%
“…With the IDH1 R132 (Arginine 132) mutation leading to an accumulation of 2 hydroxyglutarate, magnetic resonance spectroscopy (MRS) allows the measurement of this oncometabolite in vivo (49, 50), which has been applied for non-invasively predicting IDH-mutation status in glioma patients (51) and for investigating remote glioma cell infiltration in vivo (52–54). Recent studies even used MRS to identify tumor-specific metabolic profiles and investigated metabolic–transcriptional alterations under consideration of genetic profiles (5557). A multimodal approach combining MRS and a diffusion-based characterization of NAWM microarchitecture may allow future studies to further specify histopathological correlates of NAWM diffusion properties in vivo .…”
Section: Discussionmentioning
confidence: 99%
“…As in the case of our patient, complementary MRS and positron emitting tomography may also provide valuable data to identify the presence of glial tumors; further details on their application can be found elsewhere. [4,8]MS: Lesions are commonly found within the confinements of the posterior fossa, periventricular areas, spinal cord, and optic nerves. Dual-echo and fluid-attenuated inversion recovery (FLAIR) imaging reveal focal areas of hyperintensity while T1-weighted MRI (with Gd) help discerns between active and inactive MS-lesions, as enhancement results from an increase in blood-brain barrier permeability in areas of “active” inflammation.…”
Section: Discussionmentioning
confidence: 99%
“…As in the case of our patient, complementary MRS and positron emitting tomography may also provide valuable data to identify the presence of glial tumors; further details on their application can be found elsewhere. [4,8]…”
Section: Discussionmentioning
confidence: 99%
“…Tissue samples were fixed using 4% phosphate buffered formaldehyde and paraffin-embedded according to standard procedures. Analysis were performed in the Institute of Neuropathology, Medical-Center University of Freiburg as detailed described in our previous works [7,8].…”
Section: Histopathological and Molecular Diagnosticsmentioning
confidence: 99%